Welcome to our dedicated page for Newlake Capital SEC filings (Ticker: NLCP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
NewLake Capital Partners, Inc.'s SEC filings document its public-company reporting around cannabis real estate capital, quarterly financial results and annual stockholder governance. Form 8-K reports furnish earnings releases and Regulation FD investor presentations covering revenue, net income, FFO, AFFO, liquidity, debt profile, real estate assets, tenant matters and investment activity.
Definitive proxy materials describe the annual meeting process, stockholder voting mechanics and board-level governance matters for the Maryland-incorporated issuer. The filings also identify recurring exhibits tied to financial results and investor presentations.
NewLake Capital Partners, Inc. reported the results of its Annual Meeting of Stockholders held on June 4, 2026. Stockholders elected seven directors to serve until the 2027 Annual Meeting and ratified CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
There were 20,580,766 shares of common stock entitled to vote, with 13,653,797 shares represented in person or by proxy, reflecting 66.3% of eligible shares. Each director nominee received more votes “for” than “against,” and the auditor ratification also received strong support, with over 13.3 million votes in favor.
NewLake Capital Partners director Alan Jeffrey Carr reported routine equity compensation and related adjustments. He received a grant of 4,035 shares of common stock, valued using a $14.87 closing price, under the company’s 2021 Equity Incentive Plan for board service.
The grant is in the form of restricted stock units that vest 100% on June 4, 2027 or on the date of the 2027 annual stockholders’ meeting, if earlier, subject to continued service. Following these transactions, Carr directly holds 23,740 shares of common stock and indirectly holds 23,641 shares through his spouse.
NewLake Capital Partners director Joyce Johnson reported routine equity compensation. Johnson received 4,035 shares of common stock subject to restricted stock units valued using the $14.87 closing price on June 4, 2026, bringing her direct holdings to 21,065 shares. These RSUs vest 100% on the earlier of June 4, 2027 or the company’s 2027 annual stockholders meeting, assuming continued board service. Related dividend equivalent rights tied to prior RSUs for 482 underlying shares were settled in cash and simultaneously re-granted as new dividend equivalent rights covering 482 underlying common shares.
NewLake Capital Partners director Peter Wiser received an equity award tied to board service. He was granted restricted stock units covering 4,035 shares of common stock, valued using the $14.87 closing price on June 4, 2026. These RSUs vest 100% on June 4, 2027 or the 2027 annual meeting, if he continues serving. Dividend equivalent rights on earlier RSUs were settled in cash and the associated 482 rights were surrendered and simultaneously re-granted, keeping 482 dividend equivalent rights outstanding.
NewLake Capital Partners director Dina Rollman reported equity compensation and related adjustments. She received 4,035 shares of common stock subject to restricted stock units at a reference price of $14.87 per share on June 4, 2026, raising her direct holdings to 9,765 common shares.
The RSUs were granted under the 2021 Equity Incentive Plan for board service and will vest 100% on the earlier of June 4, 2027 or the company’s 2027 annual stockholders’ meeting, subject to continued service. The filing also records 482 dividend equivalent rights tied to these RSUs, including a disposition to the issuer and a new grant, both plan-driven entries rather than open-market trades.
NewLake Capital Partners, Inc. director David L. Weinstein received an equity grant tied to 4,035 shares of common stock, valued using the $14.87 closing price on June 4, 2026. These restricted stock units vest 100% on the earlier of June 4, 2027 or the company’s 2027 annual stockholder meeting, subject to continued board service. Following this award, Weinstein directly holds 31,716 shares of common stock. The filing also shows activity in 482 dividend equivalent rights, which were settled in cash and re-granted in connection with the RSUs.
NewLake Capital Partners director Gordon F. Dugan received an equity grant tied to board service. He was awarded 6,052 shares of common stock in the form of restricted stock units, using a reference price of $14.87 per share. These RSUs vest 100% on the earlier of June 4, 2027 or the company’s 2027 annual stockholder meeting, subject to continued board service.
The filing also shows activity in dividend equivalent rights linked to RSUs. Previously accrued dividend equivalent rights were settled in cash and the related rights were disposed back to the issuer, while 722.9 new dividend equivalent rights were granted for the same underlying share amount. After the new stock grant, Dugan directly holds 67,584 shares of common stock.
NewLake Capital Partners, Inc. received an amended Schedule 13G from HG Vora Capital Management, LLC and Parag Vora reporting beneficial ownership of 1,615,000 shares, representing 7.8%.
The filing states the Reporting Persons share voting and dispositive power over the 1,615,000 shares. The joint filing agreement is attached as Exhibit 99.1 and the statement is signed 05/15/2026.
NewLake Capital Partners, Inc. President and CEO Anthony Coniglio reported an open-market purchase of 350 shares of common stock at $14.33 per share. After this transaction, he directly owns 617,844 shares of NewLake Capital Partners common stock.
NewLake Capital Partners, Inc. reported solid but slightly lower results for the quarter ended March 31, 2026. Total revenue was $12.3 million, down from $13.2 million a year earlier, mainly because three cultivation facilities in Pennsylvania, Nevada and Massachusetts are currently vacant and produced no rent.
Net income attributable to common stockholders was $5.8 million, or $0.28 per diluted share, compared with $6.3 million, or $0.31 per diluted share, as lower rental income was only partly offset by reduced operating and professional expenses. The balance sheet remained conservative, with total assets of $417.6 million, net real estate of $366.6 million and just $7.6 million drawn on a $90 million revolving credit facility.
As of March 31, 2026, NewLake owned 34 cannabis-focused properties in 12 states, with 31 leased on long-term triple-net terms and three being actively marketed for new tenants. One Hartford, Connecticut asset is classified as held for sale at a carrying value of about $4.8 million, supported by make‑whole protection from the tenant. The company highlighted tenant concentration, including Curaleaf, Cresco Labs and Trulieve, and noted that The Cannabist Company has entered restructuring proceedings but remained current on rent, backed by roughly $0.5 million of security deposits. Contractual minimum rent under existing leases totals about $601.6 million over future years, and the board declared a quarterly cash dividend of $0.43 per share.